Sun Pharmaceutical Industries Ltd.

View in App
999.35 +11.85 ▲1.2%

02 June 2023, 04:01:00 PM
Volume: 41,742

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sunpharma.com
Market Cap 239,777.54 Cr.
Enterprise Value(EV) 240,205.13 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 35.32 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 28.30 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 233.38 Trailing Twelve Months Ending 2023-03
Price to Book Value 4.28 Calculated using Price: 999.35
Dividend Yield 1.15 Period Ending 2022-03
No. of Shares Subscribed 239.93 Cr. 2,399,334,970 Shares
FaceValue 1
About Sun Pharmaceutical Industries Ltd.
The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.

Sun Pharmaceutical Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Sun Pharmaceutical Industries Ltd. Performance

View details >>
1 Day
+1.20%
1 Week
+2.96%
1 Month
+2.77%
3 Month
+3.54%
6 Month
-3.89%
1 Year
+16.26%
2 Year
+47.47%
5 Year
+106.95%
10 Year
+91.17%

Sun Pharmaceutical Industries Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.15 24.89 19.32 22.51 6.85 8.05 9.66 4.98 7.21
Return on Capital Employed (%) 25.46 25.06 18.64 21.48 8.40 8.68 10.07 5.66 9.25
Return on Assets (%) 16.21 14.60 11.39 14.08 4.24 5.17 6.58 3.54 5.20

Sun Pharmaceutical Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 18,525 25,638 32,982 36,640 38,314 41,409 45,264 46,463 48,011 55,995
Non Curr. Liab. 1,748 2,335 2,170 600 46 77 246 -1,515 -1,364 -1,643
Curr. Liab. 5,990 16,147 13,144 17,887 19,864 17,340 15,706 16,146 17,201 19,907
Minority Int. 1,921 2,851 4,085 3,791 3,884 3,314 3,860 3,017 3,055 3,320
Equity & Liab. 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903 77,579
Non Curr. Assets 9,498 18,056 22,440 25,964 30,473 31,070 33,423 33,668 31,888 37,696
Curr. Assets 18,686 28,916 29,934 32,947 31,636 31,069 31,654 30,442 35,015 39,883
Misc. Exp. not W/O 0
Total Assets 28,184 46,972 52,381 58,917 62,109 62,139 65,077 64,110 66,903 77,579

Sun Pharmaceutical Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 16,080 27,392 28,109 31,308 26,416 29,066 32,838 33,498 38,654 43,886
Other Income 552 566 658 1,030 912 1,059 652 859 1,437 780
Total Income 16,633 27,958 28,767 32,338 27,328 30,125 33,489 34,357 40,092 44,666
Total Expenditure -9,081 -19,543 -19,950 -21,626 -20,881 -22,792 -25,863 -25,030 -28,773 -32,385
PBIDT 7,552 8,414 8,817 10,712 6,447 7,333 7,626 9,327 11,319 12,281
Interest -44 -579 -523 -400 -518 -555 -303 -141 -127 -172
Depreciation -409 -1,195 -1,038 -1,265 -1,500 -1,753 -2,053 -2,080 -2,144 -2,529
Taxation -702 -915 -914 -1,212 -911 -601 -823 -515 -1,076 -848
Exceptional Items -2,517 -238 -685 -951 -1,214 -261 -4,306 -4,567 -171
PAT 3,879 5,488 5,657 7,836 2,568 3,209 4,187 2,285 3,406 8,561
Minority Interest -738 -936 -1,113 -882 -447 -542 -407 631 -117 -39
Share Associate -13 1 10 -25 -1 -15 -12 -17 -48
Other Related Items
Consolidated Net Profit 3,141 4,539 4,546 6,964 2,096 2,665 3,765 2,904 3,273 8,474
Adjusted EPS 15 22 19 29 9 11 16 12 14 35

Sun Pharmaceutical Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 3,357 3,959 5,616 6,686 7,082 3,907 2,196 6,555 6,170 8,985
Cash Fr. Inv. -2,635 -2,367 -2,866 -4,372 -4,222 -3,371 -681 -2,589 536 -5,725
Cash Fr. Finan. -665 507 -1,187 -1,889 -2,285 -1,539 -2,731 -5,715 -5,980 -5,193
Net Change 57 2,099 1,563 426 575 -1,003 -1,215 -1,749 726 -1,934
Cash & Cash Eqvt 2,069 4,359 7,286 8,032 8,642 7,906 7,062 5,677 6,273 4,508

Sun Pharmaceutical Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48 54.48
Public 45.52 45.52 45.52 45.52 45.52 45.52 45.53 45.52 45.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 8.62 6.36 6.52 4.79 5.57 4.04 2.53 1.92 1.78

Sun Pharmaceutical Industries Ltd. Announcements

View details >>
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q4 FY23 Earnings Call Transcript
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to Sun Pharma and Philogen enter into an Exclusive Distribution License and Supply Agreement for Commercializing specialty product NIDLEGY™ in Europe Australia and New Zealand which we shall be releasing after sending this letter to you. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis which we shall be releasing after sending this letter to you. This submission is being made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Sun Pharmaceutical Industries Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Sun Pharmaceutical Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Zydus Lifesciences Ltd. 52,487.85 519.40 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 26.82 519.40 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 3.00 519.40 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 519.40 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 519.40 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 519.40 +1.2%

Sun Pharmaceutical Industries Ltd. FAQ's

What is Sun Pharma Inds. share price?
Can I buy Sun Pharma Inds. shares now?
What is the Dividend Yield of Sun Pharma Inds.?
What is the Market Cap of Sun Pharma Inds.?
What are the key metrics to analyse Sun Pharma Inds.?
What is the 52 Week High and Low of Sun Pharma Inds.?
What is the trend of Sun Pharma Inds. share price?